Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-09

Clinical Trial Update: Caffeine and Intermittent Claudication [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating caffeine for intermittent claudication has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caffeine (caffeine)

Snippet

Sponsor: University of Aarhus | Conditions: Intermittent Claudication | Phase 3 | Status: COMPLETED